Aster DM Healthcare Limited

rs,

30, 2026 To The Secretary, Listing Department, BSE Limited, 1st Floor, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai 400001. To The Manager, Listing Department, The National Stock Exchange of

18%

h aided by steady Patient Volume growth ▪ The combined entity1 (on a proforma basis) delivered an 18% YoY growth in Revenue, reaching INR 2,361 crores in Q4FY26 ▪ Total Patient Volumes grew by 12% Yo

INR 2,361 crore

wth ▪ The combined entity1 (on a proforma basis) delivered an 18% YoY growth in Revenue, reaching INR 2,361 crores in Q4FY26 ▪ Total Patient Volumes grew by 12% YoY reaching 1.93 Mn with occupancy increasing 210

12%

an 18% YoY growth in Revenue, reaching INR 2,361 crores in Q4FY26 ▪ Total Patient Volumes grew by 12% YoY reaching 1.93 Mn with occupancy increasing 210 bps to 61% in Q4FY26 ▪ ARPP IP grew by 8% YoY r

210 bps

ores in Q4FY26 ▪ Total Patient Volumes grew by 12% YoY reaching 1.93 Mn with occupancy increasing 210 bps to 61% in Q4FY26 ▪ ARPP IP grew by 8% YoY reaching 129,779 in Q4FY26. Improved CONGO Mix (by over

61%

Y26 ▪ Total Patient Volumes grew by 12% YoY reaching 1.93 Mn with occupancy increasing 210 bps to 61% in Q4FY26 ▪ ARPP IP grew by 8% YoY reaching 129,779 in Q4FY26. Improved CONGO Mix (by over 200 bps

8%

w by 12% YoY reaching 1.93 Mn with occupancy increasing 210 bps to 61% in Q4FY26 ▪ ARPP IP grew by 8% YoY reaching 129,779 in Q4FY26. Improved CONGO Mix (by over 200 bps) as well as Payor Mix (Cash & I

200 bps

to 61% in Q4FY26 ▪ ARPP IP grew by 8% YoY reaching 129,779 in Q4FY26. Improved CONGO Mix (by over 200 bps) as well as Payor Mix (Cash & Insuran ce at 83%) for the year. Robust EBITDA Growth Reflecting Ope

83%

129,779 in Q4FY26. Improved CONGO Mix (by over 200 bps) as well as Payor Mix (Cash & Insuran ce at 83%) for the year. Robust EBITDA Growth Reflecting Operational leverage and Effective Cost Management;

25%

ent; Improvement in RoCE Reflecting better asset utilisation ▪ The merged entity1 delivered robust 25% YoY EBITDA2 growth (27% ex. Kasargod) to INR 517 crores in Q4FY26 ▪ The EBITDA2 margins at 21.9% (

27%

Reflecting better asset utilisation ▪ The merged entity1 delivered robust 25% YoY EBITDA2 growth (27% ex. Kasargod) to INR 517 crores in Q4FY26 ▪ The EBITDA2 margins at 21.9% (22.4% ex. Kasargod) in Q

INR 517 crore

set utilisation ▪ The merged entity1 delivered robust 25% YoY EBITDA2 growth (27% ex. Kasargod) to INR 517 crores in Q4FY26 ▪ The EBITDA2 margins at 21.9% (22.4% ex. Kasargod) in Q4FY26 as compared with 20.7% in

“INR 150 Cr up by 35% Operating EBITDA Margin1 (In %) 22.3% 23.5% 2,405 2,007 2,108 1,690 1,318 875 935 FY20 FY21 FY22 FY23 FY24 FY25 FY26 592 493 430 356 255 124 124 FY20 FY21 FY22 FY23 FY24 FY25 FY26 21.0% 21.4% 19.4% 23.4% 24.6% 14.2% 13.2% 1.”

“Operationalised in April’2026 300 454 460 100 100 150 130 550 250 6,8308,177 8,177 5,449 75 159 FY27 : 688 beds FY28 : 760 beds FY29 : 480 beds FY30 and”

“Three Year Revenue & Operating EBITDA CAGR and 3 Year Capex are till the year ending FY26 6.”

“Kerala hospital and bed count excludes WIMS PECs: Patient Experience Centers ; ALOS: Average Length of Stay; ARPOB: Average revenue per occupied bed Our Presence/Strength1 16 Cities and 5 States 202 Hospitals 5,449 Capacity beds 10 Clinics 304 Labs and PECs 203 Pharmacies3 Operational metrics (FY26) 61% Occupancy 3.1 days ALOS INR 51,800 ARPOB Financial metrics (FY26) Revenue INR 4,643 Cr Op.”

“Operating EBITDA for the period FY26 excludes the ESOP Cost of Rs.”

“8.3 Cr [FY25: 8.4 Cr], Movement in fair value of contingen t consideration payable of Rs.”

“Nil Cr [FY25 : 0.8 Cr] , Variable O&M fee amounting to Rs.37.3 Cr [FY25 : 31.8 Cr].”

“The Normalised PAT for FY26 excludes exceptional income of ₹38.4 Cr [FY25: Nil Cr] arising from minimum wage reversal, as wel l as exceptional expenses of ₹71.1 Cr [FY25: 50.1 Cr], which includes merger related costs, CSR expenses related to profits from the sale of the GCC business and Other provisions.”

“Aster India overall numbers are after eliminations of INR 119 Cr (FY25: 117 Cr.) of intercompany revenue and INR 105 Cr.”

“(FY25: INR 77 Cr.) of unallocated expenses.”

Highlights

3

Ex-Kasargod Revenue

1

Ex-Kasargod Op. EBITDA

1

Beyond

1

Projects Current Status

1

Aster CMI

1

Aster Whitefield

1

Investor Relations

1

Highlights

Q4FY26 Q4FY25 604 587 142 150 23.5% 25.6% 499 499 111 111 22.3% 22.3% YoY 21% 18% 27% 35% 114 bps 330 bps • Kerala cluster achieved strong revenue growth of 21% YoY in Q4FY26 driven by growth in volume, MVT and contribution from the newly operationalized Kasargod hospital, despite temporary minor impact due to Nurses' Strike. o Total patient volume increased 20% YoY (Inpatient by 11%, Outpatient by 20%) o MVT business revenue steadily increased by 51% YoY despite macro economic headwinds o ARPP (IP) grew 5% YoY, supported by an improved case mix • Operating EBITDA grew significantly by 27% YoY (35% YoY ex-Kasargod) with margin at 23.5% (25.6% ex. Kasargod) in Q4FY26, led by cost efficiencies and operating leverage in manpower and overhead costs. Revenue (In INR Cr) 499 604 Q4FY26 Q4FY25

Ex-Kasargod Op. EBITDA

INR 150 Cr up by 35% Operating EBITDA Margin1 (In %) 22.3% 23.5% 2,405 2,007 2,108 1,690 1,318 875 935 FY20 FY21 FY22 FY23 FY24 FY25 FY26 592 493 430 356 255 124 124 FY20 FY21 FY22 FY23 FY24 FY25 FY26 21.0% 21.4% 19.4% 23.4% 24.6% 14.2% 13.2% 1. 1. From FY19 to FY22 is reported as EBITDA and FY23 onwards it is operating EBITDA Q4FY25 Q4FY26 Ex-Kasargod Op. EBITDA Margin: 25.6% FY20 FY21 FY22 FY23 FY24 FY25 FY26 28 Page title 24 pt 22 77 146 Page subtitle 20pt non bold 22 77 146 Heading Font color – 22 77 146 Line: 22 77 146 Excel color scheme A1: A2: A3: A4: A5: A6: A7: A8: 22 77 146 129 129 129 0 180 141 0 72 57 74 144 228 148 176 200 206 231 254 218 219 221 For client A1: 22 77 146 For CS A3: 0 180 141 Highlight in tables H1: 218 219 221 H2: 188 208 222 Karnataka & Maharashtra Cluster: Hospitals and Bed Capacity Revenue Contribution1 34% 502 377 252 Aster CMI Bengaluru, Karnataka 2014, O&M Aster Whitefield Bengaluru, Karnataka 2021, Leased Aster RV Bengaluru, Karnataka 2019, O&M Plan

Highlights

▪ Revenue grew 11% YoY supported by strong growth in ARPP (IP) improvement o ARPOB grew by 13% YoY driven by o Higher complex procedures in Cardiology, Neurosciences and Ortho, particularly Robotic surgeries and DBS cases o Increase in MVT business (revenue by 16%) o De-empanelment of a low-yielding scheme at Aster Aadhar ▪ Op EBITDA grew by 25% YoY with margins at 24.5% in Q4 FY26 (267 bps YoY) ▪ Karnataka o Aster Whitefield revenue grew by 15% YoY in Q4FY26 supported by strong growth in IP Volumes o Overall IP volume delivered a growth of 3% YoY in Karnataka o As stated earlier, executed on hiring and retention strategies for a few doctor positions. Cluster is well positioned for accelerated growth in coming quarters Highlight in tables ▪ Maharashtra o Aster Aadhar revenue grew by 14% on account of improvement in ARPP IP due to rationalisation of scheme business (in line with our stated strategy) Revenue (In INR Cr) 355 394 1553 1408 1100 817 655 442 433 Q4FY25 Q4FY26 FY20 FY21 FY22

Highlights

▪ A&T Revenue grew 30% YoY led by growth in IP volume and ARPP (IP) o Ramesh Hospitals revenue grew by 32% YoY in Q4 FY26 o Total patient volume increased by 20% YoY (Inpatient by 17%, Outpatient by 21%) o ARPP IP remained healthy with 13% YoY growth supported by 200 bps improvement in CONGO Mix ▪ A&T cluster Operating EBITDA doubled with the growth of 113% YoY o Margins exhibited significant increase reaching 18.3% in Q4 FY26 from 11.2% in Q4FY25 Page title 24 pt 22 77 146 Page subtitle 20pt non bold 22 77 146 Heading Font color – 22 77 146 Line: 22 77 146 Excel color scheme A1: A2: A3: A4: A5: A6: A7: A8: 22 77 146 129 129 129 0 180 141 0 72 57 74 144 228 148 176 200 206 231 254 218 219 221 For client A1: 22 77 146 For CS A3: 0 180 141 Highlight in tables H1: 218 219 221 H2: 188 208 222 Highlights: narrative pending Revenue (In INR Cr) 151 116 542 473 412 314 279 370 344 Q4FY25 Q4FY26 FY20 FY21 FY22 FY23 FY24 FY25 FY26 Operating EBITDA1 (In INR Cr) 28 13 69 47 45 41 32 73 60 Q4FY25 Q

Beyond

800 beds Current Aster Ramesh Ongole Aster Whitefield Block D Aster Capital* Trivandrum Aster Hyderabad* Aster Sarjapur* Aster CMI** Phase I Aster Medcity** MIMS Calicut ** MIMS Kannur ** Aster** Yeshwanthpur Aster CMI** Phase II Projected Leased Leased Owned Leased Leased O&M Owned Owned Owned Leased O&M

Projects Current Status

*Aster Capital, Aster W&C Hyderabad and Aster Sarjapur are in construction phase ** Aster CMI, Aster Medcity (PMR block), MIMS Calicut, MIMS Kannur and Aster Yeshwanthpur are in design phase. Brownfield:- 964 beds; Greenfield:- 1,764 beds. 33 Page title 24 pt 22 77 146 Page subtitle 20pt non bold 22 77 146 Heading Font color – 22 77 146 Line: 22 77 146 Excel color scheme A1: A2: A3: A4: A5: A6: A7: A8: 22 77 146 129 129 129 0 180 141 0 72 57 74 144 228 148 176 200 206 231 254 218 219 221 For client A1: 22 77 146 For CS A3: 0 180 141 Highlight in tables H1: 218 219 221 H2: 188 208 222 Key Greenfield Expansion Aster Yeshwanthpur, Bengaluru Aster Sarjapur, Bengaluru Aster Capital, Trivandrum Aster Hyderabad Multispecialty | 550 Beds Multispecialty | 460 Beds Multispecialty | 454 Beds Mother and Child Care | 300 Beds 30 year long term Lease 5 lakhs sq.ft Built up Area Total Investment: INR 580 Cr Expected Timeline: FY30 Design Phase 30 year long term Lease 4.2 lakhs sq.ft Built up Area Exp